Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The Waiting Time of Prostate Cancer Patients in Poland.

Osowiecka K, Nawrocki S, Kurowicki M, Rucinska M.

Int J Environ Res Public Health. 2019 Jan 26;16(3). pii: E342. doi: 10.3390/ijerph16030342.

2.

How Long Are Cancer Patients Waiting for Oncological Therapy in Poland?

Osowiecka K, Rucinska M, Nowakowski JJ, Nawrocki S.

Int J Environ Res Public Health. 2018 Mar 23;15(4). pii: E577. doi: 10.3390/ijerph15040577.

3.

Wait times in prostate cancer diagnosis and radiation treatment.

Stevens C, Bondy SJ, Loblaw DA.

Can Urol Assoc J. 2010 Aug;4(4):243-8.

4.

Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04.

Rayson D, Saint-Jacques N, Younis T, Meadows J, Dewar R.

CMAJ. 2007 Jan 30;176(3):327-32.

5.

Waiting for radiotherapy in Ontario.

Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):221-8.

PMID:
8083117
7.

Waiting time for treatment of women with breast cancer in Podlaskie Voivodeship (Poland) in view of place of residence. A population study.

Maślach D, Krzyżak M, Szpak A, Owoc A, Bielska-Lasota M.

Ann Agric Environ Med. 2013;20(1):161-6.

8.

Radical prostatectomy versus watchful waiting in early prostate cancer.

Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Steineck G, Adami HO, Johansson JE; SPCG-4 Investigators.

N Engl J Med. 2011 May 5;364(18):1708-17. doi: 10.1056/NEJMoa1011967.

9.

[Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012].

Pourcel G, Ledesert B, Bousquet PJ, Ferrari C, Viguier J, Buzyn A.

Bull Cancer. 2013 Dec;100(12):1237-50. doi: 10.1684/bdc.2013.1832. French.

PMID:
24158562
10.

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Adami HO, Johansson JE; Scandinavian Prostate Cancer Group Study Number 4.

J Natl Cancer Inst. 2008 Aug 20;100(16):1144-54. doi: 10.1093/jnci/djn255. Epub 2008 Aug 11.

11.

Treatments for Localized Prostate Cancer: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation [Internet].

Chou R, Dana T, Bougatsos C, Fu R, Blazina I, Gleitsmann K, Rugge JB.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Oct.

12.

Nanotechnology: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 1.

13.

Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival.

van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel MW, van Dijk BA.

Oral Oncol. 2015 Mar;51(3):272-8. doi: 10.1016/j.oraloncology.2014.12.003. Epub 2014 Dec 22.

PMID:
25541458
14.

Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May.

15.

Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.

Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll PR.

J Urol. 2008 May;179(5 Suppl):S14-8. doi: 10.1016/j.juro.2008.03.132.

PMID:
18405740
16.

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.

Med Care. 2004 Mar;42(3):239-50.

PMID:
15076823
17.

"Just Another Statistic"

Machtay M, Glatstein E.

Oncologist. 1998;3(3):III-IV.

PMID:
10388105
18.

Is there a detrimental effect of waiting for radiotherapy for patients with localized prostate cancer?

Faria SL, Mahmud S, Wakil G, Negrete S, Souhami L, David M, Duclos M, Shenouda G, Freeman CR.

Am J Clin Oncol. 2006 Oct;29(5):463-7.

PMID:
17023780
19.

Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.

Kasperzyk JL, Shappley WV 3rd, Kenfield SA, Mucci LA, Kurth T, Ma J, Stampfer MJ, Sanda MG.

J Urol. 2011 Nov;186(5):1862-7. doi: 10.1016/j.juro.2011.06.058. Epub 2011 Sep 23.

20.

Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000.

Simunovic M, Thériault ME, Paszat L, Coates A, Whelan T, Holowaty E, Levine M.

Can J Surg. 2005 Apr;48(2):137-42.

Supplemental Content

Support Center